Home
>
National Drug Code (NDC)
>
Cefotaxime
Cefotaxime - 0143-9931-25 - (Cefotaxime)
Drug Information of Cefotaxime
| Product NDC: | 0143-9931 |
| Proprietary Name: | Cefotaxime |
| Non Proprietary Name: | Cefotaxime |
| Active Ingredient(s): | 1 g/1 & nbsp; Cefotaxime |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cefotaxime
| Product NDC: | 0143-9931 |
| Labeler Name: | West-ward Pharmaceutical Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065071 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021120 |
Package Information of Cefotaxime
| Package NDC: | 0143-9931-25 |
| Package Description: | 25 VIAL in 1 PACKAGE (0143-9931-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9931-01) |
NDC Information of Cefotaxime
| NDC Code | 0143-9931-25 |
| Proprietary Name | Cefotaxime |
| Package Description | 25 VIAL in 1 PACKAGE (0143-9931-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9931-01) |
| Product NDC | 0143-9931 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefotaxime |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20021120 |
| Marketing Category Name | ANDA |
| Labeler Name | West-ward Pharmaceutical Corp |
| Substance Name | CEFOTAXIME SODIUM |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
